Mereo BioPharma Group plc Notification of Director Dealing (7956P)

TIDMMPH

RNS Number : 7956P

Mereo BioPharma Group plc

14 October 2019

Mereo BioPharma Group plc

("Mereo" or the "Company")

Notification of Director Dealing

London, October 14, 2019 - Mereo BioPharma Group plc (AIM: MPH, NASDAQ: MREO), a clinical stage UK based biopharmaceutical company focused on rare diseases, received notification that on October 11, 2019, Peter Fellner, Chairman of the Board of Directors of Mereo, purchased 23,800 Ordinary Shares at a price of GBP0.60 per share. On the same day, Peter Fellner also purchased 1,700 Ordinary Shares at a price of GBP0.61 per share.

The below announcement and notification is made in accordance with the EU Market Abuse Regulation. The form required under the EU Market Abuse Regulation follows.

 
 1    Details of the person discharging managerial responsibilities 
 a)   Name                      Peter Fellner 
     ------------------------  ------------------------------------------ 
 2    Reason for the notification 
     -------------------------------------------------------------------- 
 a)   Position/status           Chairman of the Board of Directors 
     ------------------------  ------------------------------------------ 
 b)   Initial notification/     Initial notification 
       Amendment 
     ------------------------  ------------------------------------------ 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
     -------------------------------------------------------------------- 
 a)   Name                      Mereo BioPharma Group plc 
     ------------------------  ------------------------------------------ 
 b)   LEI                       213800U8JQHIJOS5AS09 
     ------------------------  ------------------------------------------ 
 4    Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions have 
       been conducted 
     -------------------------------------------------------------------- 
 a)   Description of            MEREO BIOPHARMA GROUP PLC ORDINARY SHARES 
       the financial 
       instrument, type 
       of instrument 
       and identification 
       code 
     ------------------------  ------------------------------------------ 
 b)   Nature of the             PURCHASE 
       transaction 
     ------------------------  ------------------------------------------ 
 c)   Price(s) and                Price(s)    Volume(s) 
       volume(s)                   GBP0.60     23800 
                                              ---------- 
     ------------------------  ------------------------------------------ 
 d)   Aggregated information:   Aggregated volume: 23800 
       volume, Price             Aggregated price: GBP0.60 
     ------------------------  ------------------------------------------ 
 e)   Date of the transaction   2019-10-11 
     ------------------------  ------------------------------------------ 
 f)   Place of the              AIMX 
       transaction 
     ------------------------  ------------------------------------------ 
 
 
 1    Details of the person discharging managerial responsibilities 
 a)   Name                      Peter Fellner 
     ------------------------  ------------------------------------------ 
 2    Reason for the notification 
     -------------------------------------------------------------------- 
 a)   Position/status           Chairman of the Board of Directors 
     ------------------------  ------------------------------------------ 
 b)   Initial notification/     Initial notification 
       Amendment 
     ------------------------  ------------------------------------------ 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
     -------------------------------------------------------------------- 
 a)   Name                      Mereo BioPharma Group plc 
     ------------------------  ------------------------------------------ 
 b)   LEI                       213800U8JQHIJOS5AS09 
     ------------------------  ------------------------------------------ 
 4    Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions have 
       been conducted 
     -------------------------------------------------------------------- 
 a)   Description of            MEREO BIOPHARMA GROUP PLC ORDINARY SHARES 
       the financial 
       instrument, type 
       of instrument 
       and identification 
       code 
     ------------------------  ------------------------------------------ 
 b)   Nature of the             AIMX 
       transaction 
     ------------------------  ------------------------------------------ 
 c)   Price(s) and                Price(s)    Volume(s) 
       volume(s)                   GBP0.61     1700 
                                              ---------- 
     ------------------------  ------------------------------------------ 
 d)   Aggregated information:   Aggregated volume: 1700 
       volume, Price             Aggregated price: GBP0.61 
     ------------------------  ------------------------------------------ 
 e)   Date of the transaction   2019-10-11 
     ------------------------  ------------------------------------------ 
 f)   Place of the              AIMX 
       transaction 
     ------------------------  ------------------------------------------ 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

END

DSHUSAARKKARAAA

(END) Dow Jones Newswires

October 14, 2019 07:21 ET (11:21 GMT)